| Size & multiples | |||
| Market Cap | $327.3M | Enterprise Value | $58.0M |
| P/E (TTM) | — | PEG (trailing) | — |
| P/S | 37.02× | P/FCF | — |
| EV/EBITDA | — | EV/EBIT | — |
| EV/Sales | 6.56× | EV/FCF | — |
| FCF Yield | −32.79% | Buyback Yield | — |
| Owner Earnings (TTM) | -$111.1M | Owner Earnings Yield | −33.95% |
| Shareholder Yield | — | ||
| Cost of capital & EVAmethodology → | |||
| Beta (5y monthly) | 1.09 | Risk-free (assumed) | 4.00% |
| Equity risk premium (assumed) | 5.00% | Cost of Equity | 9.44% |
| After-tax Cost of Debt | — | WACC | — |
| ROIC | −138.72% | EVA Spread (ROIC−WACC) | — |
| EVA | — | ||
Flows TTM (last 4 quarters); latest annual for: EPS (Diluted) · EPS TTM -$1.40 · revenue TTM $8.8M · FCF TTM -$107.3M
Output of a disclosed model whose assumptions may be wrong — research information, not investment advice. See the Disclaimer.
Compared against all 1054 Health Care names we cover — one sector-wide pool, so the median skews toward smaller (often unprofitable) companies. Try the Size band for a cap-matched read.
| Metric | This (FY) | Peer median | IQR (25–75) | %ile |
|---|---|---|---|---|
| FCF Yield | -29.1% | -7.8% | -34.7%–1.4% | 28 ↓weak |
| Operating Margin | -7919.4% | -34.5% | -552.0%–8.0% | 8 ↓weak |
| ROE | -41.4% | -36.8% | -92.5%–4.5% | 47 ↓weak |
